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ment in 23/26—88% (71% to 96%)—of cases. The dis-
charge destinations recommended by the geriatrician
were to a rehabilitation ward (eight patients), home
with extra support (seven), nursing home (three), NHS
continuing care (two), medicine for the elderly ward
(one), hospice (one), and medical ward (one).
Comment
The study confirmed the reliability and validity of the
instrument for the objective evaluation of the appropri-
ateness of surgical bed occupancy in a colorectal unit. A
Canadian report on the American appropriateness
evaluation protocol showed a poor validity against a
panel of experts (=0.25).2 A European version of the
protocol has been suggested but has not been validated
in a substantial study.3 The validity of our instrument
needs to be retested in other settings with a larger study
population. Whether the instrument can be used as a
tool for clinical decision making or audit needs to be
confirmed in future studies.
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Representation of South Asian people in randomised
clinical trials: analysis of trials’ data
Su Mason, Mahvash Hussain-Gambles, Brenda Leese, Karl Atkin, Julia Brown
Excluding patients of ethnic minority groups from clini-
cal trials is unethical,1 introduces substantial bias, and
means that findings are based on unrepresentative
populations.2 The National Institutes of Health Revitali-
zation Act 1993 requires that all minority groups be rep-
resented in the sample in research projects supported
by the National Institutes of Health, unless there is a
clear and compelling justification not to do so. In the
United Kingdom no such legislation exists.
Participants, methods, and results
To determine the proportion of South Asian
participants (the biggest minority ethnic group in Brit-
ain) included in clinical trials we investigated the
ethnicity profile of six clinical trials recently conducted
by the Northern and Yorkshire Clinical Trials and
Research Unit, University of Leeds. All were phase III,
multicentre, randomised, controlled trials and had
recruited large numbers of participants and centres.
Two were national breast cancer trials for which
regional recruitment figures were available; two were
national gynaecological trials (of different surgical
techniques for hysterectomy and for ovarian cancer);
one was a national, minimally invasive trial of surgery
in colorectal cancer; and the sixth was a regional study
investigating the eradication of Helicobacter pylori in
general practice. None contained exclusion criteria
that were directly related to ethnic origin, but all
patients’ information sheets and consent forms were in
the English language only.
We identified ethnic origin in the baseline data of
three trials and identified South Asian patients by an
SQL programming query. For the three remaining
trials, we analysed the names of the participants by
using a computer program (Nam Pehchan) developed
by Bradford Health Authority. Researchers experi-
enced in analysing South Asian names manually
checked for discrepancies. The Nam Pehchan pro-
gramme was not infallible. It did not differentiate
between different Muslim surnames (for example,
South Asian, Far Eastern, or Arabic). Therefore,
forenames (which are often more specific to language
or region than surnames) were needed to identify
some South Asian participants.
South Asian (Indian, Pakistani, and Bangladeshi)
people comprised up to 1.7% (mean 0.6%) of total par-
ticipants in the six trials (table). A community trial in
Leeds and Bradford recruited the highest number of
South Asian participants, but this number was lower
than expected compared with estimates of population
figures from the Office for National Statistics.3
Comment
People of South Asian ethnic origin seem to be under-
represented in clinical trials. Though not previously
supported by data, this has been of concern to
researchers. This under-representation might be due
to investigator bias, inappropriate strategies for
recruitment, or cost issues—for example, for translators
or translations of information sheets.4
Such inequality in the ethnic origin of participants in
trials has ethical and scientific ramifications because
genetic predisposition, dietary intake, and exposure to
environmental and occupational hazards lead to ethnic
differences in susceptibility to diseases. Furthermore,
patients’ response to drugs, how they metabolise drugs,
and their concurrent diseases, as well as the side effects
of drugs, can vary between different ethnic groups.5
Our small survey used only the rather crude
comparative data available for the expected South
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Asian population. We would have liked to compare
more precisely the trials’ inclusion criteria of age range
and sex with those of the expected South Asian popu-
lation, but this information is not currently available.
Trials that recruited older patients would not be
expected to comprise a percentage of South Asian
people equal to the overall figures of the Office for
National Statistics because the number of elderly
South Asian people in the UK population is small.
Increased awareness and monitoring of recruit-
ment and retention of ethnic minority groups in clini-
cal trials are needed, and analysis of data by ethnicity of
subjects should be done consistently. More rigorous
review by the research ethics committee of clinical trial
protocols, payment for translation of information sup-
plied to participants, community participation, and
education of ethnic minority groups may contribute to
attaining proportional representation of ethnic
minorities in trials.
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Average energy intake among pregnant women carrying a
boy compared with a girl
Rulla M Tamimi, Pagona Lagiou, Lorelei A Mucci, Chung-Cheng Hsieh, Hans-Olov Adami,
Dimitrios Trichopoulos
The birth weight of boys is about 100 g heavier than
the birth weight of girls, and this seems to be
consistent across populations. No study, has examined
whether the difference is because the pregnant
woman has a higher energy intake or more efficient
energy utilisation if she is carrying a male embryo
than if she is carrying a female embryo. We report
data to support the first hypothesis—that the pregnant
woman carrying a boy has a higher energy intake.
Participants, methods, and results
We analysed data from an international prospective
study on dietary and non-dietary predictors of
pregnancy hormones and outcomes among women
in Boston, United States, and Shanghai, China.1
Because the database of nutrients for the Chinese diet
is incomplete, we present data on dietary intakes for
the US women only.
Between March 1994 and October 1995, we
identified 402 eligible pregnant women during their
first routine prenatal visit at the Beth Israel Hospital in
Boston and invited them to participate in the study. We
followed throughout their pregnancies the 304 women
who consented and did not have an early pregnancy
termination or twin birth. The study population, study
design, and methods have been described.1
Proportion of South Asian participants in six multicentre clinical trials
Trial type
Trial population
Recruitment figures
No (%) South Asian
participantsSex Age (years) Recruitment
Hysterectomy Female >18 (mean 41.2 (SD 8)) National 1380 randomised 8 (0.6%)
Cancer:
Colorectal Male and female >18 (mean 69; range 25-94) National 584 on whom ethnicity
data are available
1 (0.2%)
Breast Female
(post-menopausal)
Mean 64 Regional 780 randomised 2 (0.3%)
Breast Female
(post-menopausal)
Most >55 Regional 133 randomised 0 (0%)
Ovarian Female >18* Regional 480 registered
(242 randomised)
3 (0.6%)
National 559 registered
(300 randomised)
4 (0.7%)
Helicobacter pylori
eradication
Male and female 40-49 Regional 8407 participants 145 (1.7%)
Office for National Statistics’ latest estimates of proportion of population that is of South Asian origin are 3.8% for the Yorkshire-Humber region and 3.4% for Great
Britain as a whole.3
*Range and mean unknown.
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